Jeff Garro
Stock Analyst at Stephens & Co.
(0.68)
# 4,111
Out of 5,132 analysts
57
Total ratings
25.64%
Success rate
-14.21%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CERT Certara | Maintains: Overweight | $15 → $12 | $6.62 | +81.27% | 6 | Dec 12, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $22.39 | +42.92% | 6 | Dec 4, 2025 | |
| OPRX OptimizeRx | Maintains: Equal-Weight | $20 → $17 | $8.76 | +94.17% | 4 | Nov 17, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $2.79 | +222.58% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $11.95 | +167.78% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $12.29 | +62.73% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $19.54 | +43.30% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $174.11 | +60.82% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $1.84 | +171.74% | 4 | Mar 6, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $1.59 | +214.47% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $55 | $25.02 | +119.82% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $166.94 | +49.75% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $20.09 | -15.38% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $4.65 | +502.15% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $20.19 | -0.94% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $8.36 | -53.35% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $0.89 | +235.27% | 3 | May 6, 2022 |
Certara
Dec 12, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $6.62
Upside: +81.27%
Privia Health Group
Dec 4, 2025
Reiterates: Overweight
Price Target: $32
Current: $22.39
Upside: +42.92%
OptimizeRx
Nov 17, 2025
Maintains: Equal-Weight
Price Target: $20 → $17
Current: $8.76
Upside: +94.17%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $2.79
Upside: +222.58%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $11.95
Upside: +167.78%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $12.29
Upside: +62.73%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $19.54
Upside: +43.30%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $174.11
Upside: +60.82%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $1.84
Upside: +171.74%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $1.59
Upside: +214.47%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $25.02
Upside: +119.82%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $166.94
Upside: +49.75%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $20.09
Upside: -15.38%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $4.65
Upside: +502.15%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $20.19
Upside: -0.94%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $8.36
Upside: -53.35%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $0.89
Upside: +235.27%